相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Optimization of adeno-associated viral vector-mediated transduction of the corticospinal tract: comparison of four promoters
Bart Nieuwenhuis et al.
GENE THERAPY (2021)
The Need for SMN-Independent Treatments of Spinal Muscular Atrophy (SMA) to Complement SMN-Enhancing Drugs
Niko Hensel et al.
FRONTIERS IN NEUROLOGY (2020)
AAV9-Mediated Expression of SMN Restricted to Neurons Does Not Rescue the Spinal Muscular Atrophy Phenotype in Mice
Aurore Besse et al.
MOLECULAR THERAPY (2020)
Systemic nature of spinal muscular atrophy revealed by studying insurance claims
Scott L. Lipnick et al.
PLOS ONE (2019)
Intraperitoneal delivery of a novel drug-like compound improves disease severity in severe and intermediate mouse models of Spinal Muscular Atrophy
E. Y. Osman et al.
SCIENTIFIC REPORTS (2019)
Next-generation AAV vectors-do not judge a virus (only) by its cover
Claire Domenger et al.
HUMAN MOLECULAR GENETICS (2019)
Hyperexcitability precedes motoneuron loss in the Smn2B/- mouse model of spinal muscular atrophy
K. A. Quinlan et al.
JOURNAL OF NEUROPHYSIOLOGY (2019)
Temporal and tissue-specific variability of SMN protein levels in mouse models of spinal muscular atrophy
Ewout J. N. Groen et al.
HUMAN MOLECULAR GENETICS (2018)
SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy
Marie-Therese Khairallah et al.
HUMAN MOLECULAR GENETICS (2017)
Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy
Anne Rietz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy a literature review
Ingrid E. C. Verhaart et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy
Kevin A. Kaifer et al.
JCI INSIGHT (2017)
Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy
Rachael A. Powis et al.
JOURNAL OF ANATOMY (2016)
Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset
Zhihua Feng et al.
HUMAN MOLECULAR GENETICS (2016)
Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy
Erkan Y. Osman et al.
MOLECULAR THERAPY (2016)
Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment
Palittiya Sintusek et al.
PLOS ONE (2016)
AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice
Vera Lukashchuk et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Selective Neuromuscular Denervation in Taiwanese Severe SMA Mouse Can Be Reversed by Morpholino Antisense Oligonucleotides
Te-Lin Lin et al.
PLOS ONE (2016)
SMN expression is required in motor neurons to rescue electrophysiological deficits in the SMNΔ7 mouse model of SMA
Vicki L. McGovern et al.
HUMAN MOLECULAR GENETICS (2015)
Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response
Haiyan Zhou et al.
HUMAN MOLECULAR GENETICS (2015)
Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose-response Study in Mice and Nonhuman Primates
Kathrin Meyer et al.
MOLECULAR THERAPY (2015)
SMN2 splice modulators enhance U1-pre-mRNA association and rescue SMA mice
James Palacino et al.
NATURE CHEMICAL BIOLOGY (2015)
Defining the therapeutic window in a severe animal model of spinal muscular atrophy
Kate L. Robbins et al.
HUMAN MOLECULAR GENETICS (2014)
A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy
Jeffrey M. Keil et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Enhancement of SMN protein levels in a mouse model of spinal muscular atrophy using novel drug-like compounds
Jonathan J. Cherry et al.
EMBO MOLECULAR MEDICINE (2013)
Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy
Karen K. Y. Ling et al.
HUMAN MOLECULAR GENETICS (2012)
Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models
Melissa Osborne et al.
HUMAN MOLECULAR GENETICS (2012)
Motor Neuron Rescue in Spinal Muscular Atrophy Mice Demonstrates That Sensory-Motor Defects Are a Consequence, Not a Cause, of Motor Neuron Dysfunction
Rocky G. Gogliotti et al.
JOURNAL OF NEUROSCIENCE (2012)
A Role for SMN Exon 7 Splicing in the Selective Vulnerability of Motor Neurons in Spinal Muscular Atrophy
Matteo Ruggiu et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology
Melissa Bowerman et al.
NEUROMUSCULAR DISORDERS (2012)
Identification of Novel Compounds That Increase SMN Protein Levels Using an Improved SMN2 Reporter Cell Assay
Jonathan J. Cherry et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy
James N. Sleigh et al.
DISEASE MODELS & MECHANISMS (2011)
Temporal requirement for high SMN expression in SMA mice
Thanh T. Le et al.
HUMAN MOLECULAR GENETICS (2011)
Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy
Cathleen M. Lutz et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy
Rocky G. Gogliotti et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
A feedback loop regulates splicing of the spinal muscular atrophy-modifying gene, SMN2
Francine M. Jodelka et al.
HUMAN MOLECULAR GENETICS (2010)
DIGITAL NECROSES AND VASCULAR THROMBOSIS IN SEVERE SPINAL MUSCULAR ATROPHY
Sabine Rudnik-Schoeneborn et al.
MUSCLE & NERVE (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Mouse Survival Motor Neuron Alleles That Mimic SMN2 Splicing and Are Inducible Rescue Embryonic Lethality Early in Development but Not Late
Suzan M. Hammond et al.
PLOS ONE (2010)
Vascular Perfusion Abnormalities in Infants with Spinal Muscular Atrophy
Alexandra Prufer de Queiroz Campos Araujo et al.
JOURNAL OF PEDIATRICS (2009)
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy
Lyndsay M. Murray et al.
HUMAN MOLECULAR GENETICS (2008)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
CL Lorson et al.
HUMAN MOLECULAR GENETICS (2000)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)
分享论文
